| Desitin Pharma GmbH - Orfiril long 150 mg, Retardkapseln |
| 54268 | | 01 | | Orfiril long 150 mg | | Retardkapseln | | N03AG01 | | Valproic Acid | | 19.11.1998 | | |
|
| Composition |
| natrii valproas 150 mg, color.: E 132, excipiens pro capsula. |
| Packungsbestandteile |
| Delayed release capsules | | | | | | | | Active Agent | Dose |
|---|
| Sodium Valproate | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Sodium Valproate | 150 mg |
| | | | Inactive agents | | additional_information |
|---|
| E 132 | | color. |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 025 | 100 Capsule(s) | 7.60 | 17.50 | B | SL | No |
|
